Geriatric Pharmacology and Polypharmacy

Geriatric pharmacology is the cornerstone of safe and effective care for older adults, a patient population that uses a disproportionate share of medications. Managing multiple medications, or polypharmacy, is not merely about counting pills; it involves understanding the profound and predictable ways aging alters drug behavior in the body and applying frameworks to mitigate harm. Mastering this topic is essential because inappropriate prescribing is a preventable cause of morbidity, hospitalizations, and diminished quality of life in the elderly.

The Pharmacokinetic Changes of Aging

Pharmacokinetics describes what the body does to a drug: its absorption, distribution, metabolism, and excretion. Age-related physiological changes alter each of these phases, demanding dosage adjustments and heightened vigilance.

Absorption changes are generally minor, though reduced stomach acid and slowed gastric emptying can delay the onset of some drugs. The more critical changes occur in distribution, metabolism, and excretion. With age, increased body fat and decreased lean body mass and total body water significantly alter how drugs spread throughout the body. Lipophilic drugs (fat-soluble), like diazepam, distribute into a larger fat reservoir, leading to a prolonged half-life and extended effect. Conversely, hydrophilic drugs (water-soluble), like alcohol or lithium, have a smaller volume of distribution, resulting in higher initial blood concentrations.

Metabolism primarily occurs in the liver, and aging leads to decreased hepatic blood flow and reduced enzyme activity. This means drugs that undergo high first-pass metabolism or are cleared by the liver (e.g., propranolol, warfarin) are processed more slowly. A 75-year-old may metabolize some drugs at half the rate of a 30-year-old, making standard adult doses potentially toxic.

Finally, reduced renal clearance is one of the most predictable and clinically significant changes. Glomerular filtration rate (GFR) declines with age, even when serum creatinine appears normal due to reduced muscle mass. Drugs excreted renally, such as digoxin, many antibiotics, and lithium, can accumulate to dangerous levels if doses are not adjusted. Estimating renal function using formulas like the CKD-EPI equation, which accounts for age, is a non-negotiable step in prescribing for older adults.

The Pharmacodynamic Shifts and Receptor Sensitivity

Pharmacodynamics refers to what the drug does to the body—its biochemical and physiological effects. In the elderly, altered receptor sensitivity means the end-organ response to a standard drug concentration is changed. Older patients often exhibit increased sensitivity to certain drug classes. For example, they are more sensitive to the sedative effects of benzodiazepines and the anticoagulant effects of warfarin due to changes in central nervous system and hemostatic system responsiveness. Conversely, they may show decreased sensitivity to beta-blockers. This altered sensitivity, combined with pharmacokinetic changes, makes the therapeutic window—the gap between a beneficial dose and a toxic one—dangerously narrow.

Clinical Tools: The Beers Criteria and Anticholinergic Burden

To navigate this complex landscape, clinicians use structured tools. The Beers Criteria is a widely accepted list of potentially inappropriate medications for older adults. It highlights drugs that should generally be avoided because their risks outweigh their benefits in this population. Examples include long-acting benzodiazepines (high fall risk), anticholinergic allergy medications like diphenhydramine (risk of confusion), and the muscle relaxant carisoprodol. The Beers Criteria serves as a critical safety checklist during medication review.

Relatedly, the concept of anticholinergic burden scoring quantifies the cumulative effect of medications that block acetylcholine in the brain and body. Many common drugs have anticholinergic properties (e.g., some antidepressants, antipsychotics, bladder medications, and over-the-counter sleep aids). A high cumulative score is strongly associated with cognitive impairment, delirium, constipation, dry mouth, and increased mortality. Calculating this burden helps identify which medications are prime targets for discontinuation.

The Dangers: Prescribing Cascades and Falls Risk

Polypharmacy creates self-perpetuating cycles of harm. A prescribing cascade begins when a drug causes an adverse effect that is misinterpreted as a new medical condition, leading to the prescription of yet another drug. A classic example is an older adult prescribed a non-steroidal anti-inflammatory drug (NSAID) for arthritis, which causes fluid retention and hypertension. The clinician then prescribes a diuretic for the "new" hypertension, which may lead to dehydration, electrolyte imbalance, or falls—triggering another round of interventions. Recognizing and interrupting this cascade is a key clinical skill.

Furthermore, medications are a leading modifiable risk factor for falls in the elderly. Psychoactive drugs (sedatives, antidepressants, antipsychotics), antichpertensives (which can cause orthostatic hypotension), and anticholinergics all significantly increase fall risk. A fall can be a catastrophic, life-altering event for an older person, leading to fractures, loss of independence, and institutionalization. Every medication regimen should be scrutinized through the lens of fall risk.

The Solution: Systematic Deprescribing

The proactive and supervised process of stopping or reducing medications is called deprescribing. It is a fundamental strategy for managing polypharmacy and is not simply about taking patients off medicine but about optimizing therapy. Effective deprescribing follows a structured approach:

1. Create a complete medication list, including over-the-counter and herbal products.
2. Identify potentially inappropriate medications using tools like the Beers Criteria and assess anticholinergic burden.
3. Determine which drugs can be reduced or stopped, prioritizing those with no current indication, those causing harm, or those where benefits no longer align with the patient's care goals (e.g., life expectancy, functional priorities).
4. Plan the withdrawal, which may involve tapering to avoid withdrawal syndromes.
5. Monitor closely for the return of symptoms, improvement in side effects, or emergence of withdrawal effects.

The goal is to simplify the regimen, reduce pill burden and cost, and minimize adverse drug events, all while maintaining or improving quality of life.

Common Pitfalls

1. Failing to Adjust for Renal Function: Using a "normal" serum creatinine level to assume normal kidney function. Correction: Routinely calculate estimated GFR using an age-adjusted formula for every older patient and adjust doses of renally cleared medications accordingly.

1. Treating Side Effects as New Diseases: Initiating a new medication without considering the existing drug regimen as the cause of new symptoms. Correction: When a new symptom emerges, perform a thorough medication review as the first diagnostic step to rule out a prescribing cascade.

1. Overlooking Anticholinergic Burden: Prescribing multiple medications with mild anticholinergic properties without recognizing their additive, harmful effects. Correction: Use an anticholinergic burden scale during medication reconciliation to identify and replace high-burden drugs with safer alternatives.

1. Neglecting Non-Prescription Medications: Focusing only on prescribed pills and ignoring over-the-counter sleep aids, analgesics, or supplements that contribute to polypharmacy and risk. Correction: Insist on a "brown bag review" where the patient brings in all bottles and containers from their home for a complete assessment.

Summary

• Aging alters pharmacokinetics through reduced renal clearance, decreased hepatic metabolism, and changes in body composition, necessitating careful dose selection and monitoring.
• Pharmacodynamic changes like altered receptor sensitivity make older adults more vulnerable to both the therapeutic and toxic effects of many medications.
• The Beers Criteria is an essential tool for identifying potentially inappropriate medications, while assessing anticholinergic burden helps prevent cognitive and functional decline.
• Prescribing cascades and drug-induced falls risk are major, preventable harms of polypharmacy that require constant vigilance.
• Deprescribing is a systematic, patient-centered process to reduce medication burden and improve outcomes, representing a critical skill for anyone caring for older adults.